Introduction {#sec1_1}
============

Obesity has been recognized by the World Health Organization as the most visible and, at the same time, the most ignored problem of public health worldwide \[[@B1]\]. The problem of obesity affects 500 million adults \[[@B2]\]. It has been demonstrated that a BMI exceeding 35 kg/m^2^ at the age of 20 shortens life expectancy by 13 years \[[@B3]\]. People with a BMI in the 40-49.9 kg/m^2^ range had an annual risk of death nearly twice as high as those with a BMI in the 22.5-24.9 kg/m^2^ range \[[@B4]\]. It is estimated that in the USA alone obesity is the cause of more than 300,000 deaths per year \[[@B5]\]. The total annual medical cost of obesity treatment in the USA exceeds USD 140 billion, which represents 9.1% of annual medical costs \[[@B6]\]. The main causes of mortality in people with obesity are cardiovascular diseases (CVD), type-2 diabetes mellitus (DM2), and some cancers.

The American Heart Association recommends weight loss in obese patients to reduce the severity of cardiometabolic risk factors, such as metabolic syndrome, insulin resistance, DM2, hypertension, dyslipidemia, CVD, and inflammation \[[@B7]\]. Clinically significant weight loss (≥5% of the baseline body weight) is claimed to be an effective way of reducing CVD and DM2 risk factors, and should be the object of every plan of treatment \[[@B8]\]. Physical activity should be implemented in obesity therapy protocols, regardless of the baseline body weight or weight loss goals. Physical training is known to be associated with body weight loss and with reductions in cardiovascular, diabetic, and all-cause mortality, leading to an increase in life expectancy and countering the negative health impact of obesity \[[@B9],[@B10]\]. It has been shown that aerobic endurance training in particular leads to numerous health benefits, and there is great evidence for its favorable influence on weight \[[@B11]\], glucose control \[[@B12]\], endothelial function \[[@B13]\], glomerular filtration rate (GFR) \[[@B14]\], lipoprotein particle size \[[@B15]\], and concentration of high-density lipoproteins \[[@B16]\] as well as for an overall improvement in quality of life \[[@B17]\]. Aerobic endurance training is the most recommended type of exercise in the treatment of obesity \[[@B18]\]. According to the European Clinical Practice Guidelines of the European Association for the Study of Obesity (EASO), aerobic endurance training of a moderate but gradually increasing intensity, adapted to the patients' health state and ability, should be undertaken on most days of week, for 30-60 min daily, by people of all ages \[[@B19]\]. Alternatively, the results of recent research indicate numerous potential advantages of strength training in the therapy of obesity, including increases in muscle strength, prevention of sarcopenia with ageing, preservation of bone mineral density, and reduction of body fat \[[@B11],[@B20]\]. Such evidence of the benefits of the implementation of strength exercise in the treatment of obesity has initiated a discussion on the necessity of developing an optimal training program. The European Society of Hypertension and the European Society of Cardiology, in their 2013 guidelines for the management of arterial hypertension, recommend dynamic resistance training, though not isometric training, performed 2-3 days per week as a means to reduce blood pressure and improve metabolic parameters \[[@B21]\]. Strength exercises seem to be a neglected aspect of the recommendations concerning the treatment of obesity by exercise.

So far, there has been no convincing scientific evidence from well-planned trials with randomization, which might serve as a basis for revising the recommendations regarding physical activity in the treatment of obesity. This fact is complicated by data indicating that the response to physical activity is, in some aspects, dissimilar in men and women \[[@B22],[@B23]\]. It has been recently suggested that physical activity plans should be designed differently for each gender \[[@B23]\]. Therefore, a homogenous unisexual population of healthy obese women was enrolled into our study to estimate the impact of different training programs on some parameters related to obesity in this gender.

The aim of this study was to compare the influence of short-term endurance training and short term endurance strength training on anthropometric parameters, body composition, physical capacity, and the circulatory system in healthy women with abdominal obesity.

Material and Methods {#sec1_2}
====================

Study Patients {#sec2_1}
--------------

Informed consent was obtained from all subjects, and the study was approved by the Ethics Committee of Poznań University of Medical Sciences, registered as case no. 1077/12 with supplement (no. 753/13). The trial protocol has been approved by an ethical committee and thus meets the standards of the Declaration of Helsinki in its revised version of 1975 and its amendments of 1983, 1989, and 1996. From the 163 registered women with obesity screened at the outpatient clinic of the Department of Internal Medicine, Metabolic Disorders, and Hypertension, University of Medical Sciences, Poznań, Poland, a total of 44 women were enrolled.

The inclusion criteria were as follows i) written and informed consent of the subject for participation in the study; ii) age 18-65 years; iii) simple obesity (BMI ≥ 30 kg/m^2^); iv) waist circumference \> 80 cm; v) content of body fat assessed by electrical bioimpedance ≥ 33%; vi) stable body weight in the month prior to the trial (permissible deviation was ± 1 kg).

The exclusion criteria were i) secondary form of obesity and/or secondary form of hypertension; ii) DM2; iii) history of coronary artery disease; iv) stroke (including transient ischemic attack); v) congestive heart failure; vi) clinically significant arrhythmias or conduction disorders; vii) malignancy; viii) history of use of any dietary supplements within 3 months before the study; ix) poorly controlled hypertension (mean systolic blood pressure (SBP) \> 140 mm Hg and/or mean diastolic blood pressure (DBP) \> 90 mm Hg) during the month prior to the trial and/or necessity to modify antihypertensive treatment in the 3 months prior to the trial; x) lipid disorders requiring the implementation of drug treatment in the 3 months prior to the trial or during the trial; xi) abnormal liver, kidney, or thyroid gland function; xii) clinically significant acute or chronic inflammatory process within the respiratory, digestive, or genitourinary tract, or in the oral cavity, pharynx, or paranasal sinuses, or connective tissue disease or arthritis; xiii) history of infection in the month prior to the study; xiv) nicotine, alcohol, or drug abuse; xv) pregnancy or childbirth at enrollment or in the 3 months prior to enrollment; xvi) current lactation or lactation in the 3 months prior to enrollment; xvii) and/or any other condition that, in the opinion of the investigators, would make participation not in the best interest of the subject, or could prevent, limit, or confound the efficacy of the study. The occurrence of any of the above exclusion criteria during the trial resulted in immediate cessation of participation in the study.

Study Design {#sec2_2}
------------

The study was designed as a prospective randomized trial. Subjects were randomized into 2 groups, A and B, using a randomization list. Both groups performed 3 months of physical training. Group A underwent endurance training, while group B in parallel underwent endurance strength training of comparable exercise volume. Aside from the training, all subjects were instructed to maintain the physical activity and diet that they had been practicing. At the baseline, and after the 3 months of physical training, anthropometric and body composition measurements, physical capacity measurements, and circulatory system measurements were performed in both groups.

Anthropometric and Body Composition Measurements {#sec2_3}
------------------------------------------------

### Anthropometric Parameters {#sec3_1}

Anthropometric measurements were conducted with the subjects wearing light clothing and no shoes. Weight was measured to the nearest 0.1 kg and height to the nearest 0.5 cm. BMI was calculated as weight divided by height squared (kg/m^2^). Obesity was defined as BMI ≥ 30 kg/m^2^. Waist circumference (cm) was measured at the level of the iliac crest at the end of normal expiration. Hip circumference was measured at the maximum protuberance of the buttocks. Waist and hip circumferences were measured to the nearest 0.5 cm. Waist-to-hip ratio (WHR) was calculated as waist circumference divided by hip circumference.

### Analysis of Bioimpedance {#sec3_2}

Fat content was determined using analysis of bioimpedance with a Bodystat analyzer (1500 MDD®; Bodystat Ltd, Isle of Man). The analysis was performed after a night\'s rest under metabolic laboratory conditions. The fat content was determined using analysis of bioimpedance only to verify the inclusion criteria, with fat content ≥ 33% including the subject to the study.

### Dual-Energy X-Ray Absorptiometry (DXA) {#sec3_3}

Body composition analysis was assessed using DXA (GE Healthcare Lunar Prodigy Advance; GE Medical Systems, Milan, Italy). This method is considered the gold standard for body composition measurements in the case of obese individuals. The subjects were instructed not to make any intense physical effort in the 24 h prior to the examination. The subjects were given complete instructions on the examination procedure. They wore cotton T-shirt, shorts, and socks and lay on the DXA table supine and motionlessly during the testing procedure. They were instructed to remove all metal, rubber, and plastic objects that might affect the X-ray beam. The procedure took approximately 15 min. The DXA machine was reset each day according to the standard procedure to assure quality, and a spine and anthropomorphic phantom were scanned daily to the same end. The same well-trained laboratory technician positioned the subjects, performed the scans, and executed the analysis according to the operator\'s manual, using the standard analysis protocol. Total body fat mass (TBFat), total body lean mass (TBLean), and total body fat-free mass were determined using standard scan mode (in case of moderately obese subjects) or thick scan mode (in case of extremely obese subjects); the absorbed dose of radiation was 0.4 µGy and 0.8 µGy, respectively. For statistical analysis, the change in TBFat was calculated as the baseline measurements minus the trial completion measurements; the change in TBLean was calculated as the trial completion measurements minus the baseline measurements. The intra- and inter-subject coefficients of variation (CV% = 100 × SD/mean) ranged from 1 to 5%. The coefficient of variation for bone mass measurements was \<1%; on this instrument, the coefficients for 5 subjects scanned 6 times over a 9-month period were 2.2% for TBFat and 1.1% for TBLean.

Physical Capacity Measurements {#sec2_4}
------------------------------

To determine the subjects' physical capacity, a Graded Exercise Test (GXT) was performed on an electronically braked cycle ergometer (Kettler® DX1 Pro, Kettler, Ense, Germany). GXT is a reliable and widely used method of determining physical capacity. GXT began at a work rate of 25 W (60 rev/min). The work rate was incremented by 25 W every 2 min until the subject could no longer maintain the required pedal cadence. Each test lasted 4-14.5 min, depending on age and aerobic fitness status. The exercise tests were conducted between 8:00 and 12:00 a.m. in an air-conditioned laboratory, 2 h after consuming a light breakfast. Expired gases, minute ventilations (Ve), and heart rate (HR) during GXT were monitored continuously with an automated system (Oxycon Mobile®; Viasys Healthcare, Hoechberg, Germany). Oxygen intake (VO~2~) and carbon dioxide output (VCO~2~) was measured breath-by-breath and averaged over 15-second periods. Before each trial, the system was calibrated according to the manufacturer\'s instructions. The ambient conditions of temperature, humidity, and barometric pressure were recorded by the sensors. In a two-point volume calibration (0.2 and 2.0 l/s), the flow values were measured automatically at the set measuring points. Gas analyzer calibration was performed using the standard gas mixture of 5% CO~2~ and 16% O~2~. Peak VO~2~ was defined as the highest 15-second averaged VO~2~ obtained during the final exercise load on the test. HRpeak (bpm) was measured as the highest 15-second average value in the test. Time to exhaustion (TTE) and maximal work rate (WRmax) were also measured. To determine ventilatory threshold (VT), the V-slope method was administered using computerized regression analysis on the slopes of the CO~2~ output versus O~2~ uptake plot, which detects the beginning of the excess CO~2~ output generated from the buffering of H^+^. The method involves analyzing the behavior of VCO~2~ as a function of VO~2~ during GXT with a consequent increase in VCO~2~. This results in a transition in the relationship between VCO~2~ and VO~2~. The software supplied by Viasys Healthcare was used, supported with a visual inspection on the part of an experienced researcher. As a secondary method, the ventilatory equivalent method (VEQ method) was employed and the point at which the equivalent for oxygen (VE/VO~2~) increased without a concomitant rise in the equivalent for carbon dioxide (VE/VCO~2~) was detected. The VT was expressed as work rate (WR~VT~) and heart rate (HR~VT~).

Circulatory System Measurements {#sec2_5}
-------------------------------

Resting blood pressure was measured using a digital electronic tensiometer (model 705IT™, Omron Corporation, Kyoto, Japan). Regular or large adult cuffs were used, depending on the patient\'s arm circumference. The measure was taken fasting in the morning hours, in a sitting position with the legs uncrossed and the back and arm supported. Resting HR was measured under the same conditions, using auscultation of the heart by stethoscope.

Exercise blood pressure was measured during a GXT using a digital electronic tensiometer (model 705IT). Regular or large adult cuffs were used, depending on patient\'s arm circumference. The measurement was taken during maximal work rate. Exercise HR was measured as the highest 15-second average value in the GXT.

Intervention {#sec2_6}
------------

The 3-month intervention consisted of a physical exercise program, including 3 sessions of training per week (on Mondays, Wednesdays, and Fridays). A total of 36 training sessions were carried out for each group. Training was performed under the supervision of a qualified and certified fitness instructor, and under medical supervision, in a professional training room situated in Sport Club City Zen, Poznań. Group A underwent endurance training on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, CO, USA). Training sessions consisted of 5 min of warm-up (stretching exercises) at low intensity (50-60% of maximum HR); 45 min of training at an intensity between 50 and 80% of maximum HR; 5 min of cycling without load, and 5 min of closing stretching and breathing exercises of low intensity. Group B underwent endurance strength training, which consisted of 5 min of warm-up (stretching exercises) of low intensity (50-60% of maximum HR), a strength component, an endurance component, cycling without load, and closing exercises. The strength component involved 20 min of strength exercises with a neck barbell and a gymnastic ball. To allow muscle power to regenerate, the strength component was variable and repeated regularly every week. On Mondays, upper limb exercises were performed with a neck barbell; Wednesdays involved spine-stabilizing exercises, deep muscle-forming exercises, and balance-adjusting exercises with a gymnastic ball; on Fridays, lower limb exercises with a neck barbell were carried out. The exercises were repeated in series. The number of repetitions of each exercise in the series was dependent on the subjects' muscle strength and was equal to the number of repetitions performed correctly. The number of repetitions was systematically increased with the increase in subjects' muscle strength. Between the series of strength exercises, 10- to 15-second regeneration pauses were taken, during which subjects performed isometric exercises. Directly after the strength exercises, the subjects underwent 25 min of endurance exercise on cycle ergometers (Schwinn Evolution) of intensity between 50 and 80% of maximum HR, 5 min of cycling without load, and 5 min of closing stretching and breathing exercises of low intensity. HR during training was monitored with a Suunto Fitness Solution® device (Suunto, Vantaa, Finland). Both training programs were comparable in exercise volume and varied only in the nature of the effort.

Dietary and Supplement Intake {#sec2_7}
-----------------------------

At baseline, every 14 days during the intervention, and upon completion of the trial, dietary intake was determined on the basis of dietary intake interviews. The amount of nutrients in the daily diet was processed and evaluated using a dietetics computer program. The intake of nutrients, total caloric intake, and caffeine consumption during the study were constant and comparable between the groups. Subjects were instructed to not use any dietary supplements.

Statistical Analysis {#sec2_8}
--------------------

Data are presented as means ± SD. All calculations and statistics were performed using STATISTICA 6.0 software (StatSoft, Inc.®, Krakow, Poland). Comparisons between groups were performed using the Mann-Whitney U test. The Wilcoxon rank sum test was used to analyze the statistical significance between variables before and after the 3-month intervention. A p value of less than 0.05 was regarded as significant. It was calculated that a sample size of at least 15 subjects in each group would yield at least 80% power of detecting an intervention effect that was statistically significant at the 0.05 α level.

Results {#sec1_3}
=======

163 subjects were examined during the pre-randomization process. 119 were excluded from the trial due to poorly controlled hypertension (49 subjects), stroke (6 subjects), history of coronary artery disease (18 subjects), congestive heart failure (16 subjects), clinically significant inflammatory process within the respiratory tract (15 subjects), abnormal liver function (9 subjects), and abnormal kidney function (6 subjects). After screening, 44 subjects fulfilled all the inclusion criteria and had no exclusion criteria. They were randomized to two equal groups, A and B, each consisting of 22 subjects. 1 subject from group A and 5 from group B were withdrawn from the trial following randomization, because of low attendance in intervention process (\<70%). 38 subjects completed the trial and underwent analysis -- 21 from group A and 17 from group B. The compliance ratio was 86.4%. No significant changes in diet were recorded. There were no statistically significant differences between the two training groups prior to the study. Baseline characteristics of the groups are presented in table [1](#T1){ref-type="table"}.

Compared with the baseline measurements, both interventions -- endurance training as well as endurance strength training -- resulted in significant decreases in body mass, BMI, waist circumference, and hip circumference. A comparison of the anthropometric parameters before and after the intervention is presented in table [2](#T2){ref-type="table"}.

Both types of intervention led to significant decreases in total body fat (%fat) and TBFat. Significant increases in TBLean and total body fat-free mass were observed only in group B (table [3](#T3){ref-type="table"}).

Compared with baseline measurements, both interventions -- endurance training as well as endurance strength training -- resulted in significant increase in VO~2peak~, WRmax, TTE, and WRVT. Also, a tendency for HR~VT~ to increase was recorded in both groups, but was not significant. A comparison of the body\'s physical capacity (GXT) parameters before and after the intervention is presented in table [4](#T4){ref-type="table"}.

Both the endurance training and the endurance strength training led to significant decreases in resting HR, resting SBP, resting DBP, and exercise DBP. A nonsignificant tendency towards an increase in exercise HR was observed in both groups. Compared with the baseline measurements, a tendency of exercise SBP to increase in group A and to decrease in group B was recorded. The comparison of circulatory system parameters before and after the intervention is presented in table [5](#T5){ref-type="table"}.

To evaluate the differences between endurance training and endurance strength training, we compared the 3-month value of each parameter with the baseline value. No significant differences were detected between the two groups for any of the studied parameters (table [6](#T6){ref-type="table"}).

Discussion {#sec1_4}
==========

Our findings show that both endurance and endurance strength training exert similar positive effects on anthropometric parameters, body composition, physical capacity, and circulatory parameters in women with abdominal obesity. This study demonstrated that key benefits could be achieved in healthy obese women after as little as 3 months of a training program.

Both types of applied exercise positively modified the anthropometric parameters of our study groups. We observed decreases in body mass (and thus BMI) as well as in waist and hip circumference. The decrease in waist circumference is especially important, as this parameter is considered to be an independent factor of cardiovascular risk \[[@B24]\]. The results of our trial are compatible with those of the research performed by Willis et al. \[[@B25]\] on obese men and women, which showed that mixed endurance strength training lead to a greater decrease in waist circumference than endurance training alone. Although the average decrease in waist circumference noted in our study was 2 cm greater in group B than in group A, this difference was statistically insignificant. Recent study conducted by Sanal et al. \[[@B23]\] on an obese population showed that mixed endurance strength training reduced the percentage of fat on the trunk in men, while decreases in fat mass on the legs were observed in the female group. On the other hand, no such relative advantage of mixed endurance strength training in weight control has been documented in the sedentary, nondiabetic, overweight, middle aged subjects considered in Studies of a Targeted Risk Reduction Intervention through Deﬁned Exercise (STRRIDE) \[[@B26]\] or in the trial performed by Davidson et al. \[[@B27]\] on abdominally obese older men and women. Noticeably, compared to our 3-month training program, the duration of the training plans applied in these two studies was 8 months and 6 months, respectively. Thus, the effect of longer-term training may be observed in those trials. In our study, we decided (like others \[[@B23],[@B28],[@B29],[@B30]\]) to focus on a shorter 3-month training program. Recently, the valuable effects of the two types of training in obese patients following 2 months of physical activity program were documented by Ghroubi et al. \[[@B31]\].

Our results reveal that endurance and endurance strength training favorably affects body composition by decreasing the total body fat and TBFat. This effect of the exercise is crucial to the treatment of obesity. Mixed endurance strength training, in contrast to endurance training, led to statistically significant increases in TBLean and total body fat-free mass. However, the differences between endurance and endurance strength training do not reach statistical significance in the case of any of the examined body composition parameters. Our findings are in contrast to earlier studies of Marzolini et al. \[[@B25]\] and Willis et al. \[[@B32]\], in which mixed endurance strength exercise was found to be more beneficial than endurance exercise with respect to total body fat percentage, TBLean, and total body fat-free mass. It is noteworthy that Marzolini et al. \[[@B25]\] performed their study on individuals with coronary artery disease -- a condition which served as exclusion criterion in our study. Also, in contrast to the 3-month training program applied in our study, 8 months of physical activity were performed in the study of Willis et al. \[[@B32]\].

Our results indicate that both types of exercise beneficially influence physical capacity as shown by a significant increase in VO~2peak~, WRmax, TTE, and WR~VT~. These parameters are widely approved predictors of cardiologic, pulmonological, and metabolic risk. Many studies showed that obesity unfavorably affects exercise capacity \[[@B33],[@B34]\] by reducing cardiorespiratory fitness compared to matched controls \[[@B33],[@B35],[@B36]\]. Also in our study, both groups of participants had low values of VO~2peak~ at baseline. Our training interventions (both endurance and mixed endurance strength training) caused statistically significant increases in cardiorespiratory fitness and exercise capacity, which confirms the observations of others \[[@B36],[@B37]\]. However, despite the tendency toward a slightly higher increase in VO~2peak~, WRmax, TTE, and WR~VT~ observed in group B, we did not show any statistically significant predominance of one particular type of training for physical capacity improvement. The nonsignificant tendency may be caused, on the one hand, by muscle strength improvement and, on the other, by the statistically significant increase in TBLean and total body fat-free mass noted after mixed endurance strength training \[[@B20],[@B38]\]. It has been recently reported that, compared to overweight women, overweight women with DM2 developed greater maximal oxygen uptake after 3 months of endurance training \[[@B39]\]. In our study, DM2 was among the exclusion criteria. In other trials on obese individuals (with a predominance of women in the studied groups), the physical capacity parameters increased significantly in the high-intensity aerobic training group when compared with the strength-trained group \[[@B30]\].

In our study, endurance and endurance strength training positively affected circulatory parameters, as shown by the decrease in resting HR, resting SBP and DBP, and exercise DBP. These parameters are generally accepted and applied markers of cardiovascular risk. We did not find any statistically significant superiority of the investigated types of exercise for any circulatory parameters during the study. Nevertheless, the published data concerning the precise influence of endurance and endurance strength training type on circulatory parameters level remains unclear and differs by studied populations. Recently, Lucotti et al. \[[@B40]\] demonstrated a greater decrease in resting SBP in the case of endurance training and an increase in resting DBP in the case of endurance strength training in obese diabetic patients on a diet. Berent et al. \[[@B41]\] recorded a decrease in resting DBP, resting SBP, and resting HR as an effect of combined endurance strength training in patients with cardiovascular disease. Similar results concerning mixed endurance strength training in relation to resting SBP and resting DBP were obtained in elderly hypertensive patients by De Moraes et al. \[[@B42]\]. The influence of endurance training on cardiovascular parameters in postmenopausal elderly women also included a significant decrease in resting SBP and resting DBP \[[@B29],[@B43],[@B44],[@B45]\]. Furthermore, an increase in maximal HR after 36 weeks of training \[[@B45]\], or no significant change in resting HR after 12 weeks of training \[[@B43]\], were reported by some authors. On the contrary, no significant changes in resting SBP and resting DBP has been seen following 6 months of training in a group of postmenopausal women \[[@B46]\]. Other studies have demonstrated a reduction in resting SBP and resting DBP after 12 weeks of regular endurance training in postmenopausal women with mildly elevated BP \[[@B47]\]. The significantly decreased resting SBP, DBP, and HR observed in our study may therefore be a consequence of the 3-month exercise program performed in the study, which allows us to estimate only the short-term effect of the training. In their exploration of mixed endurance strength training in obese middle-aged women, Seo et al. \[[@B29]\] observed a decrease in resting DBP and, unlike us, no significant tendency to decrease resting SBP. Thus, the number of analyzed women in their subgroup may (as in our case) constitute a limitation of that study \[[@B29]\]. Conversely, our results are in line with results of Kargarfard et al. \[[@B48]\], who registered decreases in resting HR, resting SBP, resting DBP, and exercise DBP, and an increase in exercise HR after endurance training in patients who had suffered myocardial infarctions. The effect of endurance and strength training on circulatory parameters in obese sedentary women has been explored in the study of Chaudhary et al. \[[@B49]\], who found that exercise HR decreased after strength training and increased after endurance training and was accompanied by significant SBP and DBP changes following physical activity \[[@B49]\]. The study of Schjerve et al. \[[@B30]\] compared the effects of strength training and endurance training of moderate and high intensity on circulatory parameters in obese adults. A lack of change in the SBP of all groups, a decrease in DBP in the endurance groups, and a lack of change in DBP in the strength group were found in the study. To draw a conclusion, Cardoso et al. \[[@B50]\] reviewed available studies regarding comparisons of the impact of endurance and strength training on blood parameters and showed that there is undoubtedly a decreasing effect of endurance training on blood pressure. Nevertheless, the decreasing effect of strength exercise on SBP and DBP was considered uncertain in that study, and this issue requires deeper investigation.

Study Limitations {#sec2_9}
-----------------

The major limitation of this study is the relatively small number of subjects completing the intervention. The main reasons for this were the very rigorous inclusion and exclusion criteria. Conversely, such criteria enabled us to select a homogenous group of subjects not encumbered by diseases or states that might significantly affect the results of the study.

Study Strong Points {#sec2_10}
-------------------

It is worth emphasizing that the subjects' compliance ratio was over 85%. Participation in training was also very high, which strongly enhances the credibility of the study. A large variety of parameters were measured and compared in the same study group. The inclusion and exclusion criteria were very strict, eliminating the influence of disrupting factors. The greatest strength of the study is its comparative character, which allowed a clear result regarding the superiority of one of the forms of training to be drawn. This approach was present only in few previous studies.

Conclusions {#sec2_11}
-----------

Our findings demonstrate strong evidence for a favorable effect of 3 months of endurance and endurance strength training on anthropometric parameters, body composition, physical capacity, and circulatory system function in women with abdominal obesity. The observed benefits were comparable for both types of exercise, and further studies on a large scale and with long-term follow up should be considered to draw a precise conclusion.
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###### 

Baseline characteristics of study groups

  Variables                  Group A (n = 21)     Group B (n = 17)     p value
  -------------------------- -------------------- -------------------- ---------
  Age, years                 51.3 ± 8.3           48.2 ± 11.2          NS
  Body mass, kg              91.7 ± 11.8          94.5 ± 13.4          NS
  BMI, kg/m^2^               35.2 ± 3.9           34.9 ± 3.8           NS
  Waist circumference, cm    110.8 ± 10.2         111.6 ± 11.3         NS
  Hip circumference, cm      115.0 ± 8.0          115.8 ± 9.4          NS
  WHR                        0.96 ± 0.06          0.96 ± 0.07          NS
  Resting HR, bpm            79.7 ± 14.1          75.2 ± 8.1           NS
  Resting SBP, mm Hg         138.1 ± 11.9         141.4 ± 18.4         NS
  Resting DBP, mm Hg         83.2 ± 10.9          84.8 ± 11.6          NS
  Total body fat, %fat       47.5 ± 4.0           46.9 ± 3.7           NS
  Total body lean mass, g    45,969.0 ± 5,468.3   47,843.9 ± 6,280.4   NS
  VO~2peak,~ ml/(kg × min)   17.3 ± 2.1           18.3 ± 3.3           NS
  HR~peak,~ bpm              146.0 ± 18.0         154.6 ± 23.3         NS
  WR~max~, W                 104.8 ± 17.0         113.2 ± 23.6         NS

NS = Not significant.

###### 

Comparison of anthropometric parameters before and after the intervention in groups A and B

  Variables                 Group A before intervention (n = 21)   Group A after intervention (n = 21)   p value[^a^](#T2F1){ref-type="table-fn"}   Group B before intervention (n = 17)   Group B after intervention (n = 17)   p value[^a^](#T2F1){ref-type="table-fn"}
  ------------------------- -------------------------------------- ------------------------------------- ------------------------------------------ -------------------------------------- ------------------------------------- ------------------------------------------
  Body mass, kg             91.7 ± 11.8                            89.5 ± 11.8                           \<0.001                                    94.5 ± 13.4                            91.8 ± 13.7                           0.003
  BMI, kg/m^2^              35.2 ± 3.9                             34.3 ± 3.9                            \<0.001                                    34.9 ± 3.8                             33.9 ± 4.1                            \<0.001
  Waist circumference, cm   110.8 ± 10.2                           105.5 ± 11.1                          \<0.001                                    111.7 ± 11.3                           104.0 ± 10.5                          \<0.001
  Hip circumference, cm     115.0 ± 8.0                            111.7 ± 8.5                           \<0.001                                    115.8 ± 9.4                            112.4 ± 9.7                           0.001
  WHR                       0.96 ± 0.06                            0.94 ± 0.07                           0.01                                       0.96 ± 0.07                            0.92 ± 0.07                           0.01

P values test the hypothesis of no differences in the studied parameters between baseline and month 3.

###### 

Comparison of body composition (DXA) parameters before and after the intervention in groups A and B

  Variables                     Group A before intervention (n = 21)   Group A after intervention (n = 21)   p value[^a^](#T3F1){ref-type="table-fn"}   Group B before intervention (n = 17)   Group B after intervention (n = 17)   p value[^a^](#T3F1){ref-type="table-fn"}
  ----------------------------- -------------------------------------- ------------------------------------- ------------------------------------------ -------------------------------------- ------------------------------------- ------------------------------------------
  Total body fat, %fat          47.5 ± 4.0                             45.5 ± 3.7                            \<0.001                                    46.9 ± 3.7                             44.9 ± 3.7                            \<0.001
  Total body fat mass, g        41,954.6 ± 7,602.7                     39,218.6 ± 7,258.0                    \<0.001                                    42,692.8 ± 8,615.0                     40,024.9 ± 8,442.5                    \<0.001
  Total body lean mass, g       45,969.0 ± 5,468.3                     46,597.9 ± 5,961.1                    NS                                         47,843.9 ± 6,280.4                     48,640.1 ± 6,390.6                    \<0.001
  Total body fat-free mass, g   48,709.4 ± 5,589.2                     49,287.8 ± 6,090.4                    NS                                         50,773.7 ± 6,482.9                     51,537.1 ± 6,580.7                    \<0.001

NS = Not significant.

P values test the hypothesis of no differences in studied parameters between baseline and month 3.

###### 

Comparison of physical capacity (GXT) parameters before and after the intervention in groups A and B

  Variables                  Group A before intervention (n = 21)   Group A after intervention (n = 21)   p value[^a^](#T4F1){ref-type="table-fn"}   Group B before intervention (n = 17)   Group B after intervention (n = 17)   p value[^a^](#T4F1){ref-type="table-fn"}
  -------------------------- -------------------------------------- ------------------------------------- ------------------------------------------ -------------------------------------- ------------------------------------- ------------------------------------------
  VO~2peak,~ ml/(kg × min)   17.3 ± 2.1                             20.4 ± 3.3                            \<0.001                                    18.3 ± 3.3                             22.1 ± 4.6                            \<0.001
  WR~max,~ W                 104.8 ± 17.0                           131.0 ± 26.1                          \<0.001                                    113.2 ± 23.6                           142.6 ± 21.2                          \<0.001
  TTE, s                     470.2 ± 86.2                           575.5 ± 114.6                         \<0.001                                    524.4 ± 104.7                          653.8 ± 124.9                         \<0.001
  WR~VT~, W                  78.8 ± 14.7                            97.5 ± 19.7                           \<0.001                                    89.1 ± 18.2                            112.5 ± 20.4                          \<0.001
  HR~VT~, BPM                130.3 ± 14.5                           132.7 ± 16.9                          NS                                         137.3 ± 16.3                           138.5 ± 12.6                          NS

NS = Not significant.

P values test the hypothesis of no differences in studied parameters between baseline and month 3.

###### 

Comparison of circulatory system parameters before and after the intervention in groups A and B

  Variables             Group A before intervention (n = 21)   Group A after intervention (n = 21)   p value[^a^](#T5F1){ref-type="table-fn"}   Group B before intervention (n = 17)   Group B after intervention (n = 17)   p value[^a^](#T5F1){ref-type="table-fn"}
  --------------------- -------------------------------------- ------------------------------------- ------------------------------------------ -------------------------------------- ------------------------------------- ------------------------------------------
  Resting HR, bpm       79.7 ± 14.1                            72.2 ± 7.9                            0.007                                      75.2 ± 8.1                             71.8 ± 5.3                            0.033
  Exercise HR, bpm      146.0 ± 18.0                           147.4 ± 21.3                          NS                                         154.6 ± 23.3                           155.6 ± 19.7                          NS
  Resting SBP, mm Hg    138.1 ± 11.9                           131.4 ± 12.8                          0.002                                      141.4 ± 18.4                           132.5 ± 14.3                          0.003
  Resting DBP, mm Hg    83.2 ± 10.9                            77.7 ± 8.8                            0.003                                      84.8 ± 11.6                            80.8 ± 9.9                            0.018
  Exercise SBP, mm Hg   169.3 ± 31.6                           176.7 ± 30.8                          NS                                         182.4 ± 25.3                           179.0 ± 24.5                          NS
  Exercise DBP, mm Hg   101.1 ± 27.0                           72.0 ± 23.3                           0.001                                      91.5 ± 17.0                            75.0 ± 17.3                           \<0.001

NS = Not significant.

P values test the hypothesis of no differences in studied parameters between baseline and month 3.

###### 

Comparison of change in studied parameters from baseline to the 3-month point of the intervention in groups A and B

  Variables                       Group A (n = 21)       Group B (n = 17)       p value
  ------------------------------- ---------------------- ---------------------- ---------
  Δ body mass, kg                 −2.20 ± 2.12           −2.71 ± 2.25           NS
  Δ BMI, kg/m^2^                  −0.84 ± 0.80           −0.99 ± 0.80           NS
  Δ waist circumference, cm       −5.26 ± 4.45           −7.65 ± 4.56           NS
  Δ hip circumference, cm         −3.33 ± 2.83           −3.41 ± 3.58           NS
  Δ WHR                           −0.02 ± 0.03           −0.04 ± 0.05           NS
  Δ total body fat, %fat          −2.00 ± 1.11           −2.05 ± 1.23           NS
  Δ total body fat mass, g        −2,735.95 ± 1,703.59   −2,667.88 ± 1,885.40   NS
  Δ total body lean mass, g       628.86 ± 1,720.78      796.12 ± 757.95        NS
  Δ total body fat-free mass, g   578.38 ± 1,661.16      763.41 ± 729.28        NS
  Δ VO~2peak~, ml/(kg × min)      3.03 ± 2.45            3.82 ± 2.05            NS
  Δ WR~max~, W                    26.2 ± 19.0            29.4 ± 13.2            NS
  Δ TTE, s                        104.5 ± 67.9           129.4 ± 54.0           NS
  Δ WR~VT~, W                     19.7 ± 15.8            23.4 ± 6.2             NS
  Δ HR~VT~, bpm                   2.4 ± 10.2             1.2 ± 10.2             NS
  Δ resting HR, bpm               −7.43 ± 11.32          −3.41 ± 6.04           NS
  Δ exercise HR, bpm              1.43 ± 9.68            0.94 ± 7.7.64          NS
  Δ resting SBP, mm Hg            −6.76 ± 8.91           −8.88 ± 10.50          NS
  Δ resting DBP, mm Hg            −5.48 ± 7.52           −3.94 ± 6.19           NS
  Δ exercise SBP, mm Hg           7.38 ± 22.33           −3.35 ± 24.62          NS
  Δ exercise DBP, mm Hg           −29.10 ± 35.05         −16.47 ± 15.67         NS

NS = Not significant.
